![]() The right and bottom sides of the word "LYNKEUS" and the design are black, as are the concave surfaces of the letter "S" and the first strand, and provide a three-dimensional appearance, as if the word "LYNKEUS" and the design are illuminated from the upper left, thereby highlighting the upper and left surfaces of the simulated three-dimensional logo, and leaving the lower and right surfaces in simulated shadow, further against a dropped shadow on a background of gray.MBDA has successfully demonstrated LynkEUs Dismounted firing the MMP with target designation made by a Novadem drone. The first strand is in the color blue and the second strand is in the color red. The design consists of a first strand which runs from the upper left to the lower right, and the first strand crosses a second strand which runs form the upper right to the lower left. ![]() The words "LYNKEUS BioTech" are in the color blue. The mark consists of stylized words and a design. Scientific research technical research in the field of chemistry, biology and diagnosis of neuronal, especially opthalmological indications like retinal degradations and of diseases related to defects in vasculature or diseases related to vasculature and of autoimmune diseases scientific research in the field of gene therapy laboratory research in the field of molecular biology, animal models and cell culture systems chemist services, biochemist services technical consultation and research in the fields of biology mission oriented research and diagnostics, namely, diagnostic services in the field of diagnostic services in the field of diseases of the eye, diseases related to defects in vasculature, and autoimmune diseases and genetic, biochemical, and medical research chemical and biochemical laboratories genealogy research in the nature of generating of gene therapy-protocols computer software development for data processing consultation in the fields of molecular biology, genetic engineering, molecular diagnostics, gene therapy, and molecular medicine research in the field of gene therapy and molecular medicineĬONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE Pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases veterinary pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases in domestic pets, live-stock, poultry, amphibians, teleosts and insects preparations for healthcare, namely, dietetic products for medical purposes in the nature of dietary supplements, diet pills, dietary drink mix for use as a meal replacement, dietary food supplements, food for medically restricted diets, and meal replacement barsĮducational services, namely, conducting seminars, lectures, academies, colloquiums, conferences, congresses, symposiums, workshops, practical training, in the field of molecular biology, genetic engineering, and molecular diagnostics ![]() Trademark is used in the following business:Ĭhemicals, namely, biochemical and molecular biological products for use in manufacture of pharmaceutical and veterinary pharmaceutical preparations for the diagnosis and therapy of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases chemicals, namely, biochemical products and molecular biological products in the nature of nucleic acid probes and antibodies for the detection of degenerative diseases of the central nervous system, the eye, vasculature, and for the detection of autoimmune diseases for scientific use The current status of the LYNKEUS BIOTECH filing isĬONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE.īased on LYNKEUS BioTech GmbH, the LYNKEUS BIOTECH The legal correspondent for LYNKEUS BIOTECH trademark is The LYNKEUS BIOTECH mark is filed in the category ofĬomputer & Software Services & Scientific Services The LYNKEUS BIOTECH trademark was assigned a Serial Number # 76412499 – by the United States Patent and Trademark Office (USPTO).Īssigned Trademark Serial Number is a Unique ID to identify the LYNKEUS BIOTECH trademark application in the USPTO. Facebook Twitter Google + LinkedIn Pinterest Email Share.
0 Comments
Leave a Reply. |